Innovation and Financial Performance in Indian Pharmaceutical Industry - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Innovation and Financial Performance in Indian Pharmaceutical Industry write by . This book was released on 2020. Innovation and Financial Performance in Indian Pharmaceutical Industry available in PDF, EPUB and Kindle.
Relationship between R&D and Financial Performance in Indian Pharmaceutical Industry
Relationship between R&D and Financial Performance in Indian Pharmaceutical Industry - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Relationship between R&D and Financial Performance in Indian Pharmaceutical Industry write by Mithun Nandy. This book was released on 2021-12-03. Relationship between R&D and Financial Performance in Indian Pharmaceutical Industry available in PDF, EPUB and Kindle. The book provides insight into different research and development (R&D) activities performed by Indian pharmaceutical companies. It describes how R&D activities have evolved in the last three decades on Indian soil. The book discusses how emerging economy like India has become the ‘Pharmacy of the World’ and how reputed and research-centric Indian drug manufacturing companies are aligning their business model by incepting the business idea as ‘Innovate in India and Serve to the World’. Subsequently, through successful implementation of the R&D activities and endeavors, Indian pharmaceutical companies have been witnessing different drug discoveries and innovations which have been performed in an indigenous manner. Contemporary marketing strategies adopted by the research-centric Indian pharmaceutical companies for selling innovative drug products across the globe, attaining global competitiveness, and maintaining a seamless supply chain through export initiatives have also been discussed in this book. Finally, the book figures out the relationship between R&D and financial performance with the help of panel data analysis (PDA), an econometric approach.
Performance of Pharmaceutical Companies in India
Performance of Pharmaceutical Companies in India - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Performance of Pharmaceutical Companies in India write by Mainak Mazumdar. This book was released on 2012-10-19. Performance of Pharmaceutical Companies in India available in PDF, EPUB and Kindle. This book explains how government support and institutional set up facilitated the evolution of the Indian pharmaceutical industry and provides an economic analysis of firm strategies due to recent policy changes. The book is useful for researchers interested in understanding the transition of a lifeline sector for an emerging economy like India. Students of public policy, health administrators and health economists who are interested in the functioning of the pharmaceutical sector that produces life saving drugs in developing nations will find this book useful. The book also provides good coverage on data envelopment analysis (DEA), a useful technique for understanding productivity and efficiency. It can provide guidance to the research students on the applicability of DEA technique to address various research questions for analysis. The book will be a valuable addition to libraries in colleges of pharmacy and medicine as well as to all other academic and research centers.
Value Relevance of Innovation in the Pharmaceutical Industry
Value Relevance of Innovation in the Pharmaceutical Industry - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Value Relevance of Innovation in the Pharmaceutical Industry write by Mary E. Schramm. This book was released on 2011. Value Relevance of Innovation in the Pharmaceutical Industry available in PDF, EPUB and Kindle. During the past three decades, the pharmaceutical industry has increased its reliance on incremental innovation to drive growth. This change in conduct reflects the industry's response to a series of changes that has impacted negatively the return on its research and development investment. This dissertation examines the relationship between these changes in conduct and financial performance. First, the structure-conduct-performance paradigm and the resource-based theory of competitive advantage are referenced to establish the basis for the dynamics of change at industry and firm levels. Then, a value relevance model is defined to study the relationship between the change in innovative focus and the change in financial performance. This research studies the brand-name pharmaceutical industry from 1980 to 2009. Data to study the relationship between innovative focus and performance are compiled from three sources. Financial data are drawn from Standard & Poor's Compustat database and firms' annual reports. Data to operationalize innovative focus are acquired from the United States Food and Drug Administration's Drugs@FDA database. The value relevance model defined for this research is evaluated using time series and pooled time series approaches. The results confirm the pharmaceutical industry's innovative focus changes significantly during the period studied. The change in innovative focus significantly drives change in financial performance. Closer analysis of strategic change at the firm level reveals some firms increase their focus on incremental innovation while others do not. Financial performance changes only for the firms that increase their focus on incremental innovation. In the long run, the financial performance of the firms that change strategy by increasing their focus on incremental innovation exceeds that of the firms that do not. This research contributes to the value-relevance literature by examining allocation of the research and development investment, rather than the magnitude of the investment, and its role in driving financial performance. The results from this research have important implications for managers as they set new-product portfolio strategy to drive superior financial performance for their firms.
Analysis of Financial Performance of Selected Pharmaceutical Companies of India
Analysis of Financial Performance of Selected Pharmaceutical Companies of India - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Analysis of Financial Performance of Selected Pharmaceutical Companies of India write by P. Rohitkumar. This book was released on 2023-02-04. Analysis of Financial Performance of Selected Pharmaceutical Companies of India available in PDF, EPUB and Kindle. GLOBAL PHARMACEUTICAL INDUSTRY The global pharmaceutical industry is worth US$ 300 billion a year, a figure projected to grow within three years to US$ 400 billion. The 10 biggest drug firms control more than one-third of this market, many with annual revenue of \ more than US$ 10 billion and profit margins of about 30%. Six are based in the \sUSA and four are based in Europe. North and South America, Europe, and Japan are expected to continue to account for a complete 85% of the global pharmaceutical market well into the 21st century. At present, businesses spend one-third of their sales income on selling their goods - nearly double what they spend on research and growth.
